Solana Company (HSDT) Financial Statements & Historical Data

Solana Company (HSDT) — Price $2.29 Financial ServicesAsset Management — NASDAQ

Latest reported results:

Detailed financial statements for Solana Company (HSDT): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year with up to 20 years of history.

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma.

Analysis Summary

Solana Company reported revenue of $6.0M in the most recent fiscal year, growing at a 5-year CAGR of 55.5%.

Trailing-twelve-month margins: gross margin 95.5%, operating margin -200.5%, net margin -13.0%.

At the current price of $2.29, HSDT has negative trailing earnings (P/E not meaningful) and an ROE of -122.85%. Market capitalisation stands at $134M.

Balance sheet quality for HSDT: current ratio of 10.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.

Income Statement (10y)

Year2016201720182019202020212022202320242025
Revenue00$478000$1.5M$661000$522000$787000$644000$520000$6.0M
Cost of Revenue0$17000$59000$910000$751000$298000$463000$583000$582000$500000
Gross Profit0-$17000$419000$586000-$90000$224000$324000$61000-$62000$5.5M
Research & Development$3.6M$14.4M$9.9M$8.1M$4.6M$6.0M$4.3M$2.9M$3.7M$3.5M
Selling, General & Admin$5.7M$8.4M$17.2M$16.5M$9.4M$12.2M$10.6M$9.3M$10.1M$23.1M
Operating Expenses$9.3M$22.8M$27.1M$24.6M$14.0M$18.4M$15.8M$12.5M$13.8M$26.6M
Operating Income-$9.3M-$22.9M-$26.7M-$24.0M-$14.1M-$18.1M-$15.5M-$12.4M-$13.9M-$21.1M
EBITDA-$6.8M-$28.0M-$28.6M-$9.6M-$13.6M-$17.8M-$14.5M-$12.1M-$13.8M-$39.6M
Interest Expense$4692000000$8340000$17000$635000
Pre-tax Income-$6.9M-$28.0M-$28.6M-$9.8M-$14.1M-$18.1M-$14.1M-$8.8M-$11.7M-$40.9M
Income Tax0000000000
Net Income-$6.9M-$28.0M-$28.6M-$9.8M-$14.1M-$18.1M-$14.1M-$8.8M-$11.7M-$40.9M
EPS$-528.62$-1316.05$-1099.19$-324.78$-294.93$-184.51$-26.06$-7.28$-4.33$-1.85
EPS (Diluted)$-524.65$-1316.05$-1099.19$-324.78$-294.93$-184.51$-26.06$-7.28$-4.33$-1.85
Shares Outstanding (Diluted)$15320$21294$26040$30116$47910$98270$539886$1.2M$2.7M$22.0M

Income Statement (Quarterly)

Year2025-Q32025-Q42026-Q12026-Q2
Revenue$697000$5.2M$3.6M$2.5M
Gross Profit$594000$5.0M$3.4M$2.4M
Operating Income-$4.9M-$8.9M-$1.7M-$8.7M
EBITDA-$352.1M$325.6M-$99.8M-$8.7M
Net Income-$352.8M$325.6M-$99.8M-$30.3M
EPS$-32.89$4.25$-1.30$-0.38
EPS (Diluted)$-32.89$4.25$-1.30$-0.38

Balance Sheet (10y)

Year2016201720182019202020212022202320242025
Cash & Equivalents$2.6M$5.6M$25.6M$5.5M$3.3M$11.0M$14.5M$5.2M$1.1M$7.3M
Short-term Investments0000000000
Receivables$399106$704000$275000$574000$230000$251000$343000$637000$6350000
Inventory00$392000$598000$389000$476000$589000$457000$1.1M$1.1M
Total Current Assets$4.0M$6.6M$27.0M$7.2M$4.7M$12.6M$16.7M$7.3M$3.4M$31.2M
Property, Plant & Equipment0$173000$554000$1.3M$576000$412000$450000$230000$1180000
Goodwill000$1.2M$759000$7630000000
Intangible Assets000$582000$527000$333000$140000$240000$196.7M
Total Assets$4.0M$6.8M$27.8M$10.3M$6.5M$14.1M$17.3M$7.7M$3.5M$303.9M
Accounts Payable0$3.5M$2.4M$1.7M$747000$1.1M$627000$531000$873000$1.9M
Short-term Debt000$172000$59000$3000$54000$4500000
Total Current Liabilities$2.3M$14.3M$18.0M$3.8M$2.4M$2.7M$2.0M$1.9M$2.2M$3.0M
Long-term Debt0000000000
Total Liabilities$4.1M$14.3M$18.0M$4.5M$2.7M$2.8M$9.1M$5.3M$2.5M$3.0M
Retained Earnings-$26.3M-$66.4M-$95.0M-$104.8M-$118.9M-$137.0M-$151.1M-$160.0M-$171.7M-$212.6M
Total Equity-$16192-$7.5M$9.9M$5.8M$3.9M$11.3M$8.2M$2.4M$1.1M$300.9M
Total Debt000$637000$91000$3000$110000$57000$120000
Net Debt-$2.6M-$5.6M-$25.6M-$4.8M-$3.2M-$11.0M-$14.4M-$5.1M-$1.1M-$7.3M
Working Capital$1.7M-$7.7M$9.0M$3.4M$2.3M$9.9M$14.7M$5.4M$1.3M$28.1M

Balance Sheet (Quarterly)

Year2025-Q32025-Q42026-Q12026-Q2
Cash & Equivalents$124.1M$7.3M$4.4M$3.6M
Total Assets$475.9M$303.9M$200.7M$176.1M
Total Liabilities$628.3M$3.0M$2.8M$10.4M
Total Equity-$152.4M$300.9M$197.9M$165.6M
Total Debt0000

Cash Flow (10y)

Year2016201720182019202020212022202320242025
Net Income-$6.9M-$28.0M-$28.6M-$9.8M-$14.1M-$18.1M-$14.1M-$8.8M-$11.7M-$40.9M
Depreciation & Amortization0$17000$59000$191000$482000$374000$306000$162000$60000$680000
Stock-based Compensation0000000$1.6M$2.5M$9.2M
Change in Working Capital$156018$1.8M-$1.0M-$2.3M-$1.0M$127000-$1.3M-$311000-$8000$230000
Operating Cash Flow-$7.9M-$19.3M-$19.6M-$21.0M-$11.7M-$13.4M-$14.3M-$10.4M-$11.0M-$16.5M
Capital Expenditure$7.9M-$190000-$440000-$278000-$63000-$54000-$17000-$29000-$5000-$44.8M
Acquisitions000-$416000$610000$6000000
Stock Repurchased0000000000
Dividends Paid0000000000
Free Cash Flow0-$19.5M-$20.1M-$21.3M-$11.8M-$13.4M-$14.3M-$10.4M-$11.0M-$61.3M

Cash Flow (Quarterly)

Year2025-Q32025-Q42026-Q12026-Q2
Operating Cash Flow-$4.0M-$6.2M-$4.8M-$11.9M
Capital Expenditure0000
Free Cash Flow-$4.0M-$6.2M-$4.8M-$11.9M
Dividends Paid0000
Stock-based Compensation$473000$7.7M$900000

Growth & Margins (10y)

Year2016201720182019202020212022202320242025
Revenue Growth (YoY)+213.0%-55.8%-21.0%+50.8%-18.2%-19.3%+1057.1%
Net Income Growth (YoY)-307.2%-2.1%+65.8%-44.5%-28.3%+22.4%+37.1%-32.7%-248.2%
EPS Growth (YoY)-149.0%+16.5%+70.5%+9.2%+37.4%+85.9%+72.1%+40.5%+57.3%
Shares Change (YoY)+39.0%+22.3%+15.7%+59.1%+105.1%+449.4%+125.2%+122.9%+713.6%
FCF Growth (YoY)-2.8%-6.1%+44.5%-13.9%-6.6%+27.1%-5.8%-454.9%
Gross Margin87.7%39.2%-13.6%42.9%41.2%9.5%-11.9%91.7%
Operating Margin-5580.5%-1604.0%-2129.5%-3475.5%-1971.5%-1929.8%-2673.7%-351.0%
EBITDA Margin-5975.7%-641.0%-2064.8%-3413.8%-1842.9%-1880.0%-2654.4%-657.7%
Net Margin-5988.1%-653.8%-2137.7%-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
FCF Margin-4196.9%-1422.3%-1785.3%-2575.1%-1820.5%-1621.9%-2124.2%-1018.7%
Effective Tax Rate-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Per-Share Data (10y)

Year2016201720182019202020212022202320242025
FCF Per Share$0.00$-916.46$-770.39$-706.50$-246.32$-136.79$-26.54$-8.59$-4.08$-2.78
Dividends Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Shares Outstanding (Basic)$15205$21294$26040$30116$47910$98270$539886$1.2M$2.7M$22.0M

What to look at in Financial Services

Asset managers, brokers, fintech, exchanges. They are not banks — look at AUM, fees and FCF quality.

Profitability

Return on Equity-122.85%
Return on Invested Capital-13.92%
Return on Assets-89.33%
Gross Margin95.53%
Operating Margin-200.47%
Net Margin-1302.78%

Financial Health

Debt / Equity0.00
Current Ratio13.31
Piotroski F-Score4
Altman Z-Score11.60

Key Ratios (10y)

Year2016201720182019202020212022202320242025
P/E-9683.23-12286.77-10937.60-3919.96-1677.73-1054.82-441.77-828.30-116.05-1.56
P/B-4806781.10-45971.1631770.446570.946124.121699.16762.543119.641285.800.21
P/S0.000.00654949.5825629.3035864.5536639.467897.6311383.782618.5910.59
Gross Margin0.0%0.0%87.7%39.2%-13.6%42.9%41.2%9.5%-11.9%91.7%
Operating Margin0.0%0.0%-5580.5%-1604.0%-2129.5%-3475.5%-1971.5%-1929.8%-2673.7%-351.0%
Net Margin0.0%0.0%-5988.1%-653.8%-2137.7%-3473.6%-1788.1%-1374.2%-2258.1%-679.6%

Related companies: CATX · ELMD · INFU · INGN · NNOX · OM · PROF

Explore sector: Financial Services · Asset Management

More sections of HSDT: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks